02UV48Z
Supplement Superior Vena Cava to No Qualifier with Zooplastic Tissue, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 2 Heart and Great Vessels |
| Operation | U Supplement |
| Body Part | V Superior Vena Cava |
| Approach | 4 Percutaneous Endoscopic |
| Device | 8 Zooplastic Tissue |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or enhance a portion of the heart or a great vessel without removing the existing structure. Common examples include patch repair of a septal defect, reinforcing a weakened area of the aortic wall, or placing material to strengthen a valve annulus during repair.
The goal is to shore up tissue that is present but insufficient on its own, whether because of a congenital hole, an aneurysm that has thinned the vessel wall, or a valve structure that needs extra support to function properly. Unlike a replacement, the body's own tissue stays in place and the added material works alongside it.
Patients typically encounter this term in the context of congenital defect closures, aortic aneurysm repairs, and valve repair techniques that use patches, rings, or other reinforcing materials rather than swapping out the whole valve or vessel.
Anatomy & Axis Detail
Superior Vena Cava
The superior vena cava collects deoxygenated blood from the head, neck, and upper extremities and delivers it to the right atrium, and it can become narrowed by chronic central line placement, prior cardiac surgery, mediastinal fibrosis, or extrinsic compression from adjacent masses. Supplementing this great vessel involves patch material sewn into the wall to enlarge a constricted lumen, often as part of a broader procedure addressing superior vena cava syndrome or as a step in complex congenital repairs such as a bidirectional cavopulmonary connection. Because the vessel runs alongside the phrenic nerve and adjacent to the aortic arch, care in dissection is documented in the operative note. The distinction between supplementing a native segment and reconstructing a surgically created conduit matters for accurate procedural description.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Zooplastic Tissue
Zooplastic Tissue designates material of animal origin, most often bovine or porcine, used to replace or reinforce human anatomic structures such as heart valves or grafts. It is procured from a non-human source and processed for implantation, setting it apart from autologous tissue taken from the patient's own body and from nonautologous tissue sourced from another human donor.
Coding & Documentation
Coders assign Supplement when the note documents that material, biological or synthetic, was added to reinforce or augment existing anatomy, such as closing a septal defect with a patch or buttressing a vessel wall. The documentation should identify the material used and confirm that native tissue was not removed and replaced, only strengthened.
The most frequent error is confusing patch closure of a defect, which is Supplement, with actual replacement of a structure, which requires taking out the original part. Another common mistake is missing that some valve repairs combine Supplement for annuloplasty ring placement with Repair for other steps done in the same operative session, each of which needs its own code.